LifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children

A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…

LifeArc funds COVID-19 drug screening hub at the University of Glasgow

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…